INS and metabolic dysfunction-associated steatotic liver disease: Evaluation of the supplementation with 250 and 500 mg/day of DHA or placebo in Italian children who had liver ultrasonography and biopsy consistent with NAFLD exhibited lower hepatic steatosis and TG, and higher insulin sensitivity with both DHA dosages [49].